News Chart Sarepta Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-17 pm EDT			5-day change	1st Jan Change
17.22 ^USD	-0.06%		-9.13%	-19.98%

Jun. 30	Sarepta Therapeutics Announces FDA Acceptance Of Supplemental New Drug Applications For Amondys 45 And Vyondys 53 For Duchenne Muscular Dystrophy	CI
Jun. 30	Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications	MT

9c3c0c3d8b4.Cst1hFkNapCTo0Ma9NsOKicDCTTReAtAj1sIAPHSGwE.Z_MbtA9GLf6r9xxprZF8XnYuZgSpETwk4h1jZZ-wVXNYrjngak87wvLIKA~0b2b99782cc12625c617a7d13ea0b99c